A Randomized Controlled Phase 3 Study on the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Idiopathic Short Stature

BACKGROUND: To evaluate the safety and efficacy of daily somatropin (Jintropin(®)), a recombinant human growth hormone, in prepubertal children with ISS in China. METHODS: This study was a multicenter, randomized, controlled, open-label, phase 3 study. All subjects were randomized 3:1 to daily somat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jinna, Fu, Junfen, Wei, Haiyan, Zhang, Gaixiu, Xiao, Yanfeng, Du, Hongwei, Gu, Wei, Li, Yanhong, Chen, Linqi, Luo, Feihong, Zhong, Yan, Gong, Haihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102803/
https://www.ncbi.nlm.nih.gov/pubmed/35573994
http://dx.doi.org/10.3389/fendo.2022.864908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102803/
https://www.ncbi.nlm.nih.gov/pubmed/35573994
http://dx.doi.org/10.3389/fendo.2022.864908

Ejemplares similares